J.P. Morgan analysts expect this week’s results to be “very good” following reports from J&J, Abbott and Intuitive Surgical.

Truist Securities analysts wrote that Medtronic and Johnson & Johnson could “be relegated to niche players” in surgical robotics.

MIM Software, which GE Healthcare acquired earlier this month, will work with Elekta to improve treatment planning and workflows.

Lumicell developed the technology to enable physicians to detect residual cancer in the breast cavity after surgery.

After the FDA issued a public safety notice and sent Exactech a warning letter, the firm agreed to recall shoulder implants due to packaging issues.

Boston Scientific has recalled an agent used to block blood flow to specific vessels due to a safety problem that has been tied to seven injuries and two deaths, the Food and Drug Administration said ...

Bruker made an offer roughly two months after Nanostring filed for bankruptcy protection and said it may restructure.

After Johnson & Johnson has doled out more than $30 billion for Abiomed, Laminar and Shockwave Medical, are more medtech deals on the way?

Under the agreement, the FDA will use rare powers to require repairs, replacements or refunds for recalled respiratory machines.

TAE Life Sciences, a pioneer in advancing Boron Neutron Capture Therapy (BNCT) for cancer treatment, proudly announces the appointment of Dr. Deepak “Dee” Khuntia, M.D., FASTRO, to its esteemed Board ...

Anne Wojcicki wants to buy all outstanding shares of the DNA testing firm, which has seen its stock slump in recent years.

While Intuitive has already placed eight new surgical robots, executives cautioned system placements could be choppy in the coming months.